Systolic blood pressure and risk of valvular heart disease: a mendelian randomization study
<p><strong>Importance</strong> Modifiable risk factors for valvular heart disease remain largely unknown, which limits prevention and treatment.</p> <p><strong>Objective</strong> To assess the association between systolic blood pressure (BP) and major valv...
Main Authors: | Nazarzadeh, M, Pinho-Gomes, A, Smith Byrne, K, Canoy, D, Raimondi, F, Ayala Solares, J, Otto, C, Rahimi, K |
---|---|
Format: | Journal article |
Published: |
American Medical Association
2019
|
Similar Items
-
Systolic blood pressure and risk of valvular heart disease: A mendelian randomization study
by: Nazarzadeh, M, et al.
Published: (2019) -
Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation: a Mendelian randomization study
by: Nazarzadeh Larzjan, M, et al.
Published: (2021) -
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
by: Rao, S, et al.
Published: (2023) -
Long-term exposure to elevated systolic blood pressure in predicting incident cardiovascular disease: evidence from large-scale routine electronic health records
by: Solares, JR, et al.
Published: (2019) -
Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies
by: Nazarzadeh, M, et al.
Published: (2022)